Addendum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S49–S67
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Kenneth Cusi, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, José León, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Abstract
Section 4, "Comprehensive Medical Evaluation and Assessment of Comorbidities," of the Standards of Care in Diabetes-2023 has been updated to reflect the current clinical knowledge and evidence in nonalcoholic fatty liver disease (NAFLD).
Topics & Concepts
MedicineDiabetes mellitusAddendumIntensive care medicineNonalcoholic fatty liver diseaseMedical careDiseaseInternal medicineFatty liverFamily medicineEndocrinologyLawPolitical scienceLiver Disease Diagnosis and TreatmentDiet and metabolism studiesDiabetes, Cardiovascular Risks, and Lipoproteins